share_log

AbbVie | 8-K/A: Poll Results of AbbVie Meeting (Amendment)

AbbVie | 8-K/A: Poll Results of AbbVie Meeting (Amendment)

艾伯维公司 | 8-K/A：艾伯维会议决议公告(修正)
美股sec公告 ·  05/09 05:06
牛牛AI助手已提取核心信息
AbbVie Inc. has announced significant changes in its executive leadership, with Robert A. Michael set to take over as Chief Executive Officer from Richard A. Gonzalez on July 1, 2024. The transition was reported in a Form 8-K filed on February 20, 2024. Michael, who will also join the Board as a Class II director, will receive an annual base salary of $1.7 million, with the potential for a 150% bonus based on performance targets. Gonzalez will assume the role of Executive Chairman with an annual salary of $1.5 million. Additionally, at AbbVie's 2024 Annual Meeting of Stockholders on May 3, 2024, Class III directors were elected, Ernst & Young LLP was ratified as the independent accounting firm, and executive compensation was approved on an advisory basis. The company will hold future say on pay votes annually. However, proposals to eliminate supermajority voting, implement simple majority voting, and issue annual reports on lobbying and patent processes were not approved by stockholders.
AbbVie Inc. has announced significant changes in its executive leadership, with Robert A. Michael set to take over as Chief Executive Officer from Richard A. Gonzalez on July 1, 2024. The transition was reported in a Form 8-K filed on February 20, 2024. Michael, who will also join the Board as a Class II director, will receive an annual base salary of $1.7 million, with the potential for a 150% bonus based on performance targets. Gonzalez will assume the role of Executive Chairman with an annual salary of $1.5 million. Additionally, at AbbVie's 2024 Annual Meeting of Stockholders on May 3, 2024, Class III directors were elected, Ernst & Young LLP was ratified as the independent accounting firm, and executive compensation was approved on an advisory basis. The company will hold future say on pay votes annually. However, proposals to eliminate supermajority voting, implement simple majority voting, and issue annual reports on lobbying and patent processes were not approved by stockholders.
艾伯维公司宣布了其执行领导层的重大变动，罗伯特·迈克尔定于2024年7月1日接替理查德·冈萨雷斯担任首席执行官。过渡是在2024年2月20日提交的8-K表格中报告的。Michael还将以二级董事的身份加入董事会，他将获得170万美元的年基本工资，根据绩效目标，有可能获得150％的奖金。冈萨雷斯将担任执行主席，年薪为150万美元。此外，在2024年5月3日的艾伯维2024年年度股东大会上，选举了三类董事，安永会计师事务所被批准为独立会计师事务所，高管薪酬在咨询基础上获得批准。该公司将对每年的薪酬投票拥有未来的发言权。但是，取消绝大多数投票、实施简单多数投票以及发布游说和专利程序年度报告的提案没有得到股东的批准。
艾伯维公司宣布了其执行领导层的重大变动，罗伯特·迈克尔定于2024年7月1日接替理查德·冈萨雷斯担任首席执行官。过渡是在2024年2月20日提交的8-K表格中报告的。Michael还将以二级董事的身份加入董事会，他将获得170万美元的年基本工资，根据绩效目标，有可能获得150％的奖金。冈萨雷斯将担任执行主席，年薪为150万美元。此外，在2024年5月3日的艾伯维2024年年度股东大会上，选举了三类董事，安永会计师事务所被批准为独立会计师事务所，高管薪酬在咨询基础上获得批准。该公司将对每年的薪酬投票拥有未来的发言权。但是，取消绝大多数投票、实施简单多数投票以及发布游说和专利程序年度报告的提案没有得到股东的批准。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

译文内容由第三方软件翻译。


牛牛AI助手部分由第三方人工智能模型基于资讯内容自动生成，只对中国内地以外的地区提供。


以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。